ID   NUFP1_HUMAN             Reviewed;         495 AA.
AC   Q9UHK0; Q8WVM5; Q96SG1;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   07-APR-2021, entry version 164.
DE   RecName: Full=Nuclear fragile X mental retardation-interacting protein 1;
DE   AltName: Full=Nuclear FMRP-interacting protein 1;
GN   Name=NUFIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT ARG-36, FUNCTION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND INTERACTION WITH FMR1.
RX   PubMed=10556305; DOI=10.1093/hmg/8.13.2557;
RA   Bardoni B., Schenck A., Mandel J.-L.;
RT   "A novel RNA-binding nuclear protein that interacts with the fragile X
RT   mental retardation (FMR1) protein.";
RL   Hum. Mol. Genet. 8:2557-2566(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 163-495.
RC   TISSUE=Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-338; SER-340 AND SER-342, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-338; SER-340 AND SER-342, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-338; SER-340 AND SER-342, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-338; SER-340 AND SER-342, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   INTERACTION WITH ZNHIT3.
RX   PubMed=28335020; DOI=10.1093/brain/awx040;
RA   Anttonen A.K., Laari A., Kousi M., Yang Y.J., Jaeaeskelaeinen T., Somer M.,
RA   Siintola E., Jakkula E., Muona M., Tegelberg S., Loennqvist T., Pihko H.,
RA   Valanne L., Paetau A., Lun M.P., Haestbacka J., Kopra O., Joensuu T.,
RA   Katsanis N., Lehtinen M.K., Palvimo J.J., Lehesjoki A.E.;
RT   "ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with
RT   cerebellar granule neuron loss.";
RL   Brain 140:1267-1279(2017).
CC   -!- FUNCTION: Binds RNA. {ECO:0000269|PubMed:10556305}.
CC   -!- SUBUNIT: Interacts with FMR1 (PubMed:10556305). Interacts with ZNHIT3
CC       (PubMed:28335020). {ECO:0000269|PubMed:10556305,
CC       ECO:0000269|PubMed:28335020}.
CC   -!- INTERACTION:
CC       Q9UHK0; P55769: SNU13; NbExp=2; IntAct=EBI-2563549, EBI-712228;
CC       Q9UHK0; Q15649: ZNHIT3; NbExp=7; IntAct=EBI-2563549, EBI-2563564;
CC       Q9UHK0; Q9NWK9: ZNHIT6; NbExp=2; IntAct=EBI-2563549, EBI-2563515;
CC       Q9UHK0; P60122: Ruvbl1; Xeno; NbExp=2; IntAct=EBI-2563549, EBI-1634999;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10556305}.
CC       Note=Distributed in the nucleus in a dot-like pattern.
CC   -!- TISSUE SPECIFICITY: Expressed in spleen, thymus, prostate, testis,
CC       ovary, small intestine, colon, peripheral blood leukocyte, heart,
CC       brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas.
CC       {ECO:0000269|PubMed:10556305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17745.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF159548; AAF15315.1; -; mRNA.
DR   EMBL; AL354816; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359706; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017745; AAH17745.1; ALT_INIT; mRNA.
DR   CCDS; CCDS9393.1; -.
DR   RefSeq; NP_036477.2; NM_012345.2.
DR   PDB; 5L85; NMR; -; B=462-495.
DR   PDBsum; 5L85; -.
DR   SMR; Q9UHK0; -.
DR   BioGRID; 117807; 126.
DR   DIP; DIP-41010N; -.
DR   IntAct; Q9UHK0; 94.
DR   MINT; Q9UHK0; -.
DR   STRING; 9606.ENSP00000368459; -.
DR   iPTMnet; Q9UHK0; -.
DR   PhosphoSitePlus; Q9UHK0; -.
DR   BioMuta; NUFIP1; -.
DR   DMDM; 134047852; -.
DR   EPD; Q9UHK0; -.
DR   jPOST; Q9UHK0; -.
DR   MassIVE; Q9UHK0; -.
DR   MaxQB; Q9UHK0; -.
DR   PaxDb; Q9UHK0; -.
DR   PeptideAtlas; Q9UHK0; -.
DR   PRIDE; Q9UHK0; -.
DR   ProteomicsDB; 84368; -.
DR   Antibodypedia; 23576; 90 antibodies.
DR   DNASU; 26747; -.
DR   Ensembl; ENST00000379161; ENSP00000368459; ENSG00000083635.
DR   GeneID; 26747; -.
DR   KEGG; hsa:26747; -.
DR   UCSC; uc001uzp.3; human.
DR   CTD; 26747; -.
DR   DisGeNET; 26747; -.
DR   GeneCards; NUFIP1; -.
DR   HGNC; HGNC:8057; NUFIP1.
DR   HPA; ENSG00000083635; Low tissue specificity.
DR   MIM; 604354; gene.
DR   neXtProt; NX_Q9UHK0; -.
DR   OpenTargets; ENSG00000083635; -.
DR   PharmGKB; PA31843; -.
DR   VEuPathDB; HostDB:ENSG00000083635.7; -.
DR   eggNOG; ENOG502QPTB; Eukaryota.
DR   GeneTree; ENSGT00390000003758; -.
DR   HOGENOM; CLU_038059_0_0_1; -.
DR   InParanoid; Q9UHK0; -.
DR   OMA; RKKDYHN; -.
DR   OrthoDB; 1394860at2759; -.
DR   PhylomeDB; Q9UHK0; -.
DR   TreeFam; TF329804; -.
DR   PathwayCommons; Q9UHK0; -.
DR   BioGRID-ORCS; 26747; 329 hits in 999 CRISPR screens.
DR   ChiTaRS; NUFIP1; human.
DR   GeneWiki; NUFIP1; -.
DR   GenomeRNAi; 26747; -.
DR   Pharos; Q9UHK0; Tbio.
DR   PRO; PR:Q9UHK0; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9UHK0; protein.
DR   Bgee; ENSG00000083635; Expressed in endothelial cell and 193 other tissues.
DR   Genevisible; Q9UHK0; HS.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0016363; C:nuclear matrix; IDA:HGNC-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:HGNC-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005726; C:perichromatin fibrils; IDA:HGNC-UCL.
DR   GO; GO:0070761; C:pre-snoRNP complex; IDA:BHF-UCL.
DR   GO; GO:0048786; C:presynaptic active zone; ISS:HGNC.
DR   GO; GO:0032991; C:protein-containing complex; IDA:BHF-UCL.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:HGNC-UCL.
DR   GO; GO:0051117; F:ATPase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IPI:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; IDA:HGNC-UCL.
DR   GO; GO:0000492; P:box C/D snoRNP assembly; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:HGNC-UCL.
DR   GO; GO:0006396; P:RNA processing; TAS:ProtInc.
DR   InterPro; IPR039136; NUFIP1-like.
DR   InterPro; IPR019496; NUFIP1_cons_dom.
DR   InterPro; IPR022755; Znf_C2H2_jaz.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR13309:SF1; PTHR13309:SF1; 1.
DR   Pfam; PF10453; NUFIP1; 1.
DR   Pfam; PF12171; zf-C2H2_jaz; 1.
DR   SMART; SM00355; ZnF_C2H2; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Metal-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   RNA-binding; Zinc; Zinc-finger.
FT   CHAIN           1..495
FT                   /note="Nuclear fragile X mental retardation-interacting
FT                   protein 1"
FT                   /id="PRO_0000245518"
FT   ZN_FING         174..196
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   MOTIF           243..260
FT                   /note="Bipartite nuclear localization signal"
FT   COMPBIAS        18..109
FT                   /note="Pro-rich"
FT   MOD_RES         338
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         342
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         403
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VARIANT         36
FT                   /note="S -> R (in dbSNP:rs1140993)"
FT                   /evidence="ECO:0000269|PubMed:10556305"
FT                   /id="VAR_026978"
FT   HELIX           463..480
FT                   /evidence="ECO:0007744|PDB:5L85"
SQ   SEQUENCE   495 AA;  56300 MW;  318418FB08071001 CRC64;
     MAEPTSDFET PIGWHASPEL TPTLGPLSDT APPRDSWMFW AMLPPPPPPL TSSLPAAGSK
     PSSESQPPME AQSLPGAPPP FDAQILPGAQ PPFDAQSPLD SQPQPSGQPW NFHASTSWYW
     RQSSDRFPRH QKSFNPAVKN SYYPRKYDAK FTDFSLPPSR KQKKKKRKEP VFHFFCDTCD
     RGFKNQEKYD KHMSEHTKCP ELDCSFTAHE KIVQFHWRNM HAPGMKKIKL DTPEEIARWR
     EERRKNYPTL ANIERKKKLK LEKEKRGAVL TTTQYGKMKG MSRHSQMAKI RSPGKNHKWK
     NDNSRQRAVT GSGSHLCDLK LEGPPEANAD PLGVLINSDS ESDKEEKPQH SVIPKEVTPA
     LCSLMSSYGS LSGSESEPEE TPIKTEADVL AENQVLDSSA PKSPSQDVKA TVRNFSEAKS
     ENRKKSFEKT NPKRKKDYHN YQTLFEPRTH HPYLLEMLLA PDIRHERNVI LQCVRYIIKK
     DFFGLDTNSA KSKDV
//
